Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03603652 · ClinicalTrials.gov registry record · NA
NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung
A NA study, sponsored by Ethicon.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03603652 is a NA study that was terminated before completion, run by Ethicon. The registered enrollment target is 10 participants.
The verdict
NCT03603652, a NA study, was terminated before completion, sponsored by Ethicon.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Patients with medically inoperable primary soft tissue lesion of the lung will have transbronchial microwave ablation performed via transbronchial approach by an interventional pulmonologist or thoracic surgeon using CT imaging. Prior to the ablation procedure, the treating physician will use endobronchial ultrasound to confirm staging. Patients will be followed for one year following the ablation procedure for efficacy and safety.
Interventions
- DEVICE Microwave Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-06-29 |
| Est. Completion | 2019-10-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03603652
The ClinicalTrials.gov registry entry for NCT03603652 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ethicon, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Microwave Ablation is the first listed.
NCT03603652 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03603652 about?
NCT03603652 is a clinical study titled "NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung". Patients with medically inoperable primary soft tissue lesion of the lung will have transbronchial microwave ablation performed via transbronchial approach by an interventional pulmonologist or thoracic surgeon using CT imaging. Prior to the ablation procedure, the treating physician will use endobr...
What is the current status of trial NCT03603652?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2018-06-29. Estimated completion is 2019-10-24.
What interventions are being tested in trial NCT03603652?
The interventions under investigation include: Microwave Ablation (DEVICE).
Who is sponsoring clinical trial NCT03603652?
This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.